down arrow

Suzhou Highfine Biotech Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: CNE1000064T6
CNY
50.12
0.11 (0.22%)

Dec 05

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

35.8163.80
Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 1.59% and Operating profit at -10.05% over the last 5 years

  • INTEREST(HY) At CNY 0.08 MM has Grown at 102.95%
2

With ROE of 5.87%, it has a attractive valuation with a 0.84 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Chemicals & Petrochemicals

stock-summary
Market cap

CNY 1,950 Million (Micro Cap)

stock-summary
P/E

14.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.48%

stock-summary
Debt Equity

-0.72

stock-summary
Return on Equity

5.87%

stock-summary
Price to Book

0.84

Revenue and Profits:
Net Sales:
134 Million
(Quarterly Results - Jun 2025)
Net Profit:
41 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.32%
0%
-6.32%
6 Months
-9.82%
0%
-9.82%
1 Year
9.43%
0%
9.43%
2 Years
-25.83%
0%
-25.83%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Suzhou Highfine Biotech Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
1.59%
EBIT Growth (5y)
-10.05%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.73
Sales to Capital Employed (avg)
0.30
Tax Ratio
13.53%
Dividend Payout Ratio
31.20%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.59%
ROE (avg)
11.81%
Valuation key factors
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
0.84
EV to EBIT
2.53
EV to EBITDA
2.07
EV to Capital Employed
0.44
EV to Sales
0.58
PEG Ratio
NA
Dividend Yield
0.48%
ROCE (Latest)
17.30%
ROE (Latest)
5.87%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.90% vs 56.18% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 14.17% vs 60.71% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "133.80",
          "val2": "132.60",
          "chgp": "0.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "41.40",
          "val2": "32.20",
          "chgp": "28.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.10",
          "val2": "1.60",
          "chgp": "156.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "41.10",
          "val2": "36.00",
          "chgp": "14.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "256.90%",
          "val2": "210.40%",
          "chgp": "4.65%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 15.89% vs -13.02% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 35.45% vs -23.49% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "447.70",
          "val2": "386.30",
          "chgp": "15.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "113.60",
          "val2": "92.20",
          "chgp": "23.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "5.60",
          "val2": "0.20",
          "chgp": "2,700.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "134.10",
          "val2": "99.00",
          "chgp": "35.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "209.00%",
          "val2": "201.50%",
          "chgp": "0.75%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
133.80
132.60
0.90%
Operating Profit (PBDIT) excl Other Income
41.40
32.20
28.57%
Interest
0.00
0.00
Exceptional Items
4.10
1.60
156.25%
Consolidate Net Profit
41.10
36.00
14.17%
Operating Profit Margin (Excl OI)
256.90%
210.40%
4.65%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.90% vs 56.18% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 14.17% vs 60.71% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
447.70
386.30
15.89%
Operating Profit (PBDIT) excl Other Income
113.60
92.20
23.21%
Interest
0.20
0.20
Exceptional Items
5.60
0.20
2,700.00%
Consolidate Net Profit
134.10
99.00
35.45%
Operating Profit Margin (Excl OI)
209.00%
201.50%
0.75%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 15.89% vs -13.02% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 35.45% vs -23.49% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Suzhou Highfine Biotech Co., Ltd. stock-summary
stock-summary
Suzhou Highfine Biotech Co., Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."